CD79A and shigellosis: Significant increases over baseline LPS-specific serum IgG and IgA titres were observed post-challenge in placebo recipients progressing to consensus shigellosis (all comparisons were statistically significant at a level of significance of p = 0·005 [RM-ANOVA]; Fig. 1b and c).